The gastric hormone ghrelin appears a useful agent to stimulate food intake in people with anorexia of illness. The loss of ghrelin's acyl group renders it inactive, thus it has been thought that subcutaneous administration may be problematic.
To investigate whether human subjects are sensitive to the effects of ghrelin administered by single subcutaneous injection.
Randomized, double-blind, placebo-controlled trial.
Sixteen healthy lean volunteers (eight men and eight women).
Fasted subjects received subcutaneous injections of ghrelin (3.6 nmol/kg) or saline. After 30 min, a buffet breakfast was served.
Ghrelin injection increased energy intake by 27% (ghrelin 5076±691 kJ versus saline 4230±607 kJ, P=0.04). Ghrelin appeared to enhance the perceived palatability of the food offered (palatability score: ghrelin 81.1±3.6 versus saline 70.0±4.4; P=0.03).
These results suggest that subcutaneous ghrelin is effective at stimulating energy intake and improving palatability and may be of direct use in the treatment of appetite loss.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Nutrition & Diabetes Open Access 16 January 2012
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Plata-Salaman CR . Strategies for potential manipulation of anorexia during acute and chronic disease. Nutrition 1995; 11 (5 Suppl): 702–704.
Neary NM, Small CJ, Wren AM, Lee JL, Druce MR, Palmieri C et al. Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J Clin Endocrinol Metab 2004; 89: 2832–2836.
Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K . Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656–660.
Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS . A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001; 50: 1714–1719.
Wren AM, Small CJ, Ward HL, Murphy KG, Dakin CL, Taheri S et al. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 2000; 141: 4325–4328.
Tschop M, Smiley DL, Heiman ML . Ghrelin induces adiposity in rodents. Nature 2000; 407: 908–913.
Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001; 86: 5992.
Enomoto M, Nagaya N, Uematsu M, Okumura H, Nakagawa E, Ono F et al. Cardiovascular and hormonal effects of subcutaneous administration of ghrelin, a novel growth hormone-releasing peptide, in healthy humans. Clin Sci (London) 2003; 105: 431–435.
Flint A, Raben A, Blundell JE, Astrup A . Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes Relat Metab Disord 2000; 24: 38–48.
Nagaya N, Kojima M, Uematsu M, Yamagishi M, Hosoda H, Oya H et al. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol Regul Integr Comp Physiol 2001; 280: R1483–R1487.
Dakin CL, Small CJ, Batterham RL, Neary NM, Cohen MA, Patterson M et al. Peripheral oxyntomodulin reduces food intake and body weight gain in rats. Endocrinology 2004; 145: 2687–2695.
Marzullo P, Verti B, Savia G, Walker GE, Guzzaloni G, Tagliaferri M et al. The relationship between active ghrelin levels and human obesity involves alterations in resting energy expenditure. J Clin Endocrinol Metab 2004; 89: 936–939.
Akamizu T, Shinomiya T, Irako T, Fukunaga M, Nakai Y, Nakai Y et al. Separate measurement of plasma levels of acylated and desacyl ghrelin in healthy subjects using a new direct ELISA assay. J Clin Endocrinol Metab 2005; 90: 6–9.
We thank Professor Malcolm Allison, Dr Mandy Donaldson, the Sir John McMichael Centre and the volunteers who participated in the study. We also thank the MRC and Wellcome Trust for support. MD and NN are funded by Wellcome Trust Clinical Research Training Fellowships, MP is funded by BBSRC and MM by a Gulbenkian Foundation Grant.
About this article
Cite this article
Druce, M., Neary, N., Small, C. et al. Subcutaneous administration of ghrelin stimulates energy intake in healthy lean human volunteers. Int J Obes 30, 293–296 (2006). https://doi.org/10.1038/sj.ijo.0803158
This article is cited by
Current Obesity Reports (2020)
European Journal of Clinical Nutrition (2018)
Nature Reviews Endocrinology (2017)
Chronic Electrical Stimulation at Acupoints Reduces Body Weight and Improves Blood Glucose in Obese Rats via Autonomic Pathway
Obesity Surgery (2015)
Nutrition & Diabetes (2012)